Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 35, Issue 4, 2012, Pages 309-317

  Soloff, Adam C ^a,b   Weirback, Heather K ^a   Ross, Ted M ^a,b,c   Barratt Boyes, Simon M ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular immunity; Dendritic cell; Innate immunity; Macrophage; Mucosal immunity

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; INFLUENZA; INNATE IMMUNITY; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; MACROPHAGE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; VIRUS LOAD;

ANIMALS; ANTIBODIES; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INTERLEUKIN-6; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; MONOCYTES; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

MUS; ORTHOMYXOVIRIDAE;

EID: 84861760723     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2012.01.012     Document Type: Article

References (62)

1. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001, 2:1144-1150.
2. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004, 5:1219-1226.
3. Lund J.M., Linehan M.M., Iijima N., Iwasaki A., Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 2006, 177:7510-7514.
4. Smit J.J., Rudd B.D., Lukacs N.W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 2006, 203:1153-1159.
5. Wang H., Peters N., Schwarze J. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 2006, 177:6263-6270.
6. de Heer H.J., Hammad H., Soullie T., Hijdra D., Vos N., Willart M.A., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004, 200:89-98.
7. Chaperot L., Blum A., Manches O., Lui G., Angel J., Molens J.P., et al. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 2006, 176:248-255.
8. Hardy A.W., Graham D.R., Shearer G.M., Herbeuval J.P. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc Natl Acad Sci U S A 2007, 104:17453-17458.
9. Langlois R.A., Legge K.L. Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells. J Immunol 2010, 184:4440-4446.
10. Geissmann F., Gordon S., Hume D.A., Mowat A.M., Randolph G.J. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010, 10:453-460.
11. Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
12. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
13. Steinman R.M., Idoyaga J. Features of the dendritic cell lineage. Immunol Rev 2010, 234:5-17.
14. Soloff A.C., Barratt-Boyes S.M. Enemy at the gates: dendritic cells and immunity to mucosal pathogens. Cell Res 2010, 20:872-885.
15. Cervantes-Barragan L., Kalinke U., Zust R., Konig M., Reizis B., Lopez-Macias C., et al. I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J Immunol 2009, 182:1099-1106.
16. Belz G.T., Smith C.M., Eichner D., Shortman K., Karupiah G., Carbone F.R., et al. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol 2004, 172:1996-2000.
17. Yoneyama H., Matsuno K., Toda E., Nishiwaki T., Matsuo N., Nakano A., et al. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 2005, 202:425-435.
18. Lee H.K., Zamora M., Linehan M.M., Iijima N., Gonzalez D., Haberman A., et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med 2009, 206:359-370.
19. Sapoznikov A., Fischer J.A., Zaft T., Krauthgamer R., Dzionek A., Jung S. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J Exp Med 2007, 204:1923-1933.
20. Toapanta F.R., Ross T.M. Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res 2009, 10:112.
21. Asselin-Paturel C., Brizard G., Pin J.J., Briere F., Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003, 171:6466-6477.
22. Soloff A.C., Liu X., Gao W., Day R.D., Gambotto A., Barratt-Boyes S.M. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection. Eur J Immunol 2009, 39:2437-2449.
23. Fukushi M., Ito T., Oka T., Kitazawa T., Miyoshi-Akiyama T., Kirikae T., et al. Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLoS One 2010, 6:e21207.
24. Vermaelen K., Pauwels R. Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights. Cytometry A 2004, 61:170-177.
25. Lin K.L., Suzuki Y., Nakano H., Ramsburg E., Gunn M.D. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 2008, 180:2562-2572.
26. McGill J., Van Rooijen N., Legge K.L. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med 2008, 205:1635-1646.
27. Kim S., Iizuka K., Kang H.S., Dokun A., French A.R., Greco S., et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002, 3:523-528.
28. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006, 7:517-523.
29. Ballesteros-Tato A., Leon B., Lund F.E., Randall T.D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol 2010, 11:216-224.
30. GeurtsvanKessel C.H., Willart M.A., van Rijt L.S., Muskens F., Kool M., Baas C., et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med 2008, 205:1621-1634.
31. Legge K.L., Braciale T.J. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 2003, 18:265-277.
32. Wolf A.I., Buehler D., Hensley S.E., Cavanagh L.L., Wherry E.J., Kastner P., et al. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J Immunol 2009, 182:871-879.
33. Wang H., Peters N., Laza-Stanca V., Nawroly N., Johnston S.L., Schwarze J. Local CD11c+ MHC class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process. J Immunol 2006, 177:2536-2542.
34. Fernandez-Sesma A., Marukian S., Ebersole B.J., Kaminski D., Park M.S., Yuen T., et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 2006, 80:6295-6304.
35. Yount J.S., Kraus T.A., Horvath C.M., Moran T.M., Lopez C.B. A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J Immunol 2006, 177:4503-4513.
36. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 2006, 7:663-671.
37. Tate M.D., Schilter H.C., Brooks A.G., Reading P.C. Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus. Viral Immunol 2011, 24:77-88.
38. Allman D., Dalod M., Asselin-Paturel C., Delale T., Robbins S.H., Trinchieri G., et al. Ikaros is required for plasmacytoid dendritic cell differentiation. Blood 2006, 108:4025-4034.
39. Bjorck P., Leong H.X., Engleman E.G. Plasmacytoid dendritic cell dichotomy: identification of IFN-alpha producing cells as a phenotypically and functionally distinct subset. J Immunol 2011, 186:1477-1485.
40. Bonnefoy F., Perruche S., Couturier M., Sedrati A., Sun Y., Tiberghien P., et al. Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol 2011.
41. Chang E.Y., Guo B., Doyle S.E., Cheng G. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 2007, 178:6705-6709.
42. Melillo J.A., Song L., Bhagat G., Blazquez A.B., Plumlee C.R., Lee C., et al. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J Immunol 2010, 184:2638-2645.
43. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006, 439:204-207.
44. Seo S.U., Kwon H.J., Ko H.J., Byun Y.H., Seong B.L., Uematsu S., et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 2011, 7:e1001304.
45. Hashimoto Y., Moki T., Takizawa T., Shiratsuchi A., Nakanishi Y. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 2007, 178:2448-2457.
46. Watanabe Y., Hashimoto Y., Shiratsuchi A., Takizawa T., Nakanishi Y. Augmentation of fatality of influenza in mice by inhibition of phagocytosis. Biochem Biophys Res Commun 2005, 337:881-886.
47. Murphy E.A., Davis J.M., McClellan J.L., Carmichael M.D., Rooijen N.V., Gangemi J.D. Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophages. J Interferon Cytokine Res 2011, 6:501-508.
48. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Pantin-Jackwood M.J., et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005, 79:14933-14944.
49. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-452.
50. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
51. Hohl T.M., Rivera A., Lipuma L., Gallegos A., Shi C., Mack M., et al. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 2009, 6:470-481.
52. Aldridge J.R., Moseley C.E., Boltz D.A., Negovetich N.J., Reynolds C., Franks J., et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A 2009, 106:5306-5311.
53. Auerbuch V., Brockstedt D.G., Meyer-Morse N., O'Riordan M., Portnoy D.A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med 2004, 200:527-533.
54. Dresing P., Borkens S., Kocur M., Kropp S., Scheu S. A fluorescence reporter model defines " Tip-DCs" as the cellular source of interferon beta in murine listeriosis. PLoS One 2010, 5:e15567.
55. Phipps-Yonas H., Seto J., Sealfon S.C., Moran T.M., Fernandez-Sesma A. Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog 2008, 4:e1000193.
56. Bosschaerts T., Guilliams M., Stijlemans B., Morias Y., Engel D., Tacke F., et al. Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling. PLoS Pathog 2010, 6:e1001045.
57. Blasius A.L., Giurisato E., Cella M., Schreiber R.D., Shaw A.S., Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 2006, 177:3260-3265.
58. McGill J., Heusel J.W., Legge K.L. Innate immune control and regulation of influenza virus infections. J Leukoc Biol 2009, 86:803-812.
59. Swiecki M., Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010, 234:142-162.
60. Lin K.L., Sweeney S., Kang B.D., Ramsburg E., Gunn M.D. CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. J Immunol 2011, 186:508-515.
61. Herold S., Steinmueller M., von Wulffen W., Cakarova L., Pinto R., Pleschka S., et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 2008, 205:3065-3077.
62. Matta B.M., Castellaneta A., Thomson A.W. Tolerogenic plasmacytoid DC. Eur J Immunol 2010, 40:2667-2676.